146 related articles for article (PubMed ID: 16119674)
21. [Undifferentiated connective tissue disease].
Bodolay E; Szegedi G
Orv Hetil; 2009 May; 150(19):867-72. PubMed ID: 19403430
[TBL] [Abstract][Full Text] [Related]
22. [Modern perspective on the development conditions and diagnosis of systemic sclerosis].
Wielosz E
Wiad Lek; 2017; 70(4):855-859. PubMed ID: 29064817
[TBL] [Abstract][Full Text] [Related]
23. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
Radulescu D; Pripon S; Ciovicescu F; Constantea NA
Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
[TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
Arias-Nuñez MC; Llorca J; Vazquez-Rodriguez TR; Gomez-Acebo I; Miranda-Filloy JA; Martin J; Gonzalez-Juanatey C; Gonzalez-Gay MA
Medicine (Baltimore); 2008 Sep; 87(5):272-280. PubMed ID: 18794710
[TBL] [Abstract][Full Text] [Related]
25. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.
Bellando-Randone S; Matucci-Cerinic M
Curr Rheumatol Rep; 2017 Sep; 19(10):65. PubMed ID: 28921059
[TBL] [Abstract][Full Text] [Related]
26. [Genetics and pathophysiology of systemic sclerosis].
Allanore Y; Boileau C
Bull Acad Natl Med; 2011 Jan; 195(1):55-65; discussion 66-7. PubMed ID: 22039703
[TBL] [Abstract][Full Text] [Related]
27. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
Thachil J
Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
[TBL] [Abstract][Full Text] [Related]
29. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
[TBL] [Abstract][Full Text] [Related]
30. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
31. [The road to early diagnosis of systemic sclerosis : the evolution of diagnostic and classification criteria in the past decades].
Frerix M; Meier FM; Müller-Ladner U
Z Rheumatol; 2013 Dec; 72(10):954-9. PubMed ID: 24337197
[TBL] [Abstract][Full Text] [Related]
32. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?
Cutolo M; Sulli A; Secchi ME; Paolino S; Pizzorni C
Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv43-6. PubMed ID: 16980724
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of scleroderma peripheral vascular disease.
Herrick A
Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535
[TBL] [Abstract][Full Text] [Related]
34. Maximum blood flow and microvascular regulatory responses in systemic sclerosis.
Gunawardena H; Harris ND; Carmichael C; McHugh NJ
Rheumatology (Oxford); 2007 Jul; 46(7):1079-82. PubMed ID: 17494087
[TBL] [Abstract][Full Text] [Related]
35. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
Ng K; Gow P
N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
[TBL] [Abstract][Full Text] [Related]
36. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
37. Carotid thrombus formation and extension during anticoagulation: a case report of large vessel disease and hypercoagulable state in systemic sclerosis.
Renard D; Heroum C
Acta Neurol Belg; 2007 Jun; 107(2):55-7. PubMed ID: 17710842
[TBL] [Abstract][Full Text] [Related]
38. The validity of systemic sclerosis diagnoses in two university hospitals in Finland.
Paltta J; Kortelainen S; Käyrä M; Pirilä L; Huhtakangas J; Palomäki A
Scand J Rheumatol; 2023 Jan; 52(1):84-87. PubMed ID: 35442148
[TBL] [Abstract][Full Text] [Related]
39. CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc).
Valentini G; Riccardi A; Vettori S; Irace R; Iudici M; Tolone S; Docimo L; Bocchino M; Sanduzzi A; Cozzolino D
Clin Exp Med; 2017 Aug; 17(3):411-414. PubMed ID: 27650429
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
Koenig M; Dieudé M; Senécal JL
Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
